Back to BlackRock, Inc. BlackRock, Inc.

TBPHTBPH
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in THERAVANCE BIOPHARMA INC

BlackRock, Inc. holds 4.6M shares of TBPH (THERAVANCE BIOPHARMA INC), worth $77.6M as of 2026-Q2. The position was increased (+6.2% shares). TBPH represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$77.6M

Current Shares

4.6M

Total Value Change

+$42.6M

Total Shares Change

+850,184

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.6M
+6.2%
$77.6M0.0%$17.00
32
2026-Q1
Increased
4.3M
+6.1%
$69.7M0.0%$13.96
31
2025-Q4
Decreased
4.1M
-0.5%
$75.8M0.0%$18.91
0
2025-Q3
Decreased
4.1M
-1.7%
$59.4M0.0%$14.43
0
2025-Q2
Increased
4.1M
+19.9%
$45.7M0.0%$11.22
35
2025-Q1
Decreased
3.5M
-7.0%
$30.8M0.0%$9.23
0
2024-Q4
New
3.7M
-
$34.9M0.0%$9.47
40

Other major holders of TBPH: BAUPOST GROUP LLC/MA

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used